| References: |
Salmeterol Xinafoate is a long-acting β2-adrenergic receptor agonist with anti-inflammatory effects, used in the treatment of asthma symptoms and chronic obstructive pulmonary disease (COPD) symptoms. For the detailed information of Salmeterol Xinafoate, the solubility of Salmeterol Xinafoate in water, the solubility of Salmeterol Xinafoate in DMSO, the solubility of Salmeterol Xinafoate in PBS buffer, the animal experiment (test) of Salmeterol Xinafoate, the cell expriment (test) of Salmeterol Xinafoate, the in vivo, in vitro and clinical trial test of Salmeterol Xinafoate, the EC50, IC50,and affinity,of Salmeterol Xinafoate, For the detailed information of Salmeterol Xinafoate, the solubility of Salmeterol Xinafoate in water, the solubility of Salmeterol Xinafoate in DMSO, the solubility of Salmeterol Xinafoate in PBS buffer, the animal experiment (test) of Salmeterol Xinafoate, the cell expriment (test) of Salmeterol Xinafoate, the in vivo, in vitro and clinical trial test of Salmeterol Xinafoate, the EC50, IC50,and affinity,of Salmeterol Xinafoate, Please contact DC Chemicals. |
